Tilray Brands (XTER:2HQ) Momentum Rank : 0 (As of Dec. 15, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Tilray Brands Momentum Rank?

Tilray Brands has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Tilray Brands Momentum Rank Related Terms

Thank you for viewing the detailed overview of Tilray Brands's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Tilray Brands Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (XTER:2HQ) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

TLRY:USA TLRY:Canada TLRY:Austria

Address

265 Talbot Street West, Leamington, ON, CAN, N8H 5L4

Website

https://www.tilray.com

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Tilray Brands Headlines

No Headlines